Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 311-320 of 486 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Effect of Agent Orange Exposure on Endocrine Tumor Aggressiveness

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Profiling of Lung Cancer for Identification of Treatment Targets and Strategies

    Jacksonville, FL

  3. MElanoma Research Lymph node prediction Implementation National_001 (MERLIN_001)

    Rochester, MN

  4. A Study of a New Molecular Approach to Blood DNA Screening for Cancer

    Rochester, MN

  5. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    Albert Lea, MN, Eau Claire, WI, La Crosse, WI, Mankato, MN

  6. A2B101-101: Obtaining Solid Tumor Tissue from Subjects Having Surgical Resection for Certain Tumor Types and Leukapheresis for CAR T-cell Therapy Manufacturing

    Rochester, MN, Jacksonville, FL

  7. A Study to Predict Response to Virotherapy and Immunotherapy by Using an Ex-Vivo Three-Dimensional Patient-Derived Organoid Model of Pediatric Urological Cancers

    Rochester, MN

  8. Evaluation of Outcomes in Metastatic Gastric and Esophageal Carcinoma in Relation to Immunotherapy

    Rochester, MN

  9. A Study to Assess Financial Burden and Its Impact on Quality of Life in Patients with Plasma Cell Disorders

    Rochester, MN

  10. Interviews About Social Determinants of Health in Southeast Asian Americans to Identify Liver Cancer Disparities

    Rochester, MN

.

Mayo Clinic Footer